Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography

Recall Insight

This FDA Devices action (record #Z-0875-2026) was formally reported on December 17, 2025, with the manufacturer initiating the action on October 24, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. GE Medical Systems, LLC is listed as the recalling firm, operating out of Waukesha, WI. Federal records indicate 1,818 (1,580 US; 238 OUS) units are affected, placing this recall in the million-unit bracket that typically triggers nationwide consumer alerts and retailer sweeps.

The documented reason for this recall is: Some Senographe Pristina systems either have a missing or an incorrect X-Ray Warning label, which is a nonconformance to FDA Regulation 21 CFR ¿1020.30(j). Distribution data in the federal record shows the product reached: U.S. and OUS.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 1 year old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.